Cargando…
SARS-CoV-2: Targeted managements and vaccine development
Infection with the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) results in diverse outcomes. The symptoms appear to be more severe in males older than 65 and people with underlying health conditions; approximately one in five individuals could be at risk worldwide. The virus’s sequen...
Autores principales: | Bakhiet, Moiz, Taurin, Sebastien |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7706592/ https://www.ncbi.nlm.nih.gov/pubmed/33293238 http://dx.doi.org/10.1016/j.cytogfr.2020.11.001 |
Ejemplares similares
-
Oral Insulin Delivery Using Poly (Styrene Co-Maleic Acid) Micelles in a Diabetic Mouse Model
por: Bahman, Fatemah, et al.
Publicado: (2020) -
Targeted vaccination and the speed of SARS-CoV-2 adaptation
por: Gandon, Sylvain, et al.
Publicado: (2022) -
Styrene maleic acid encapsulated raloxifene micelles for management of inflammatory bowel disease
por: Greish, Khaled, et al.
Publicado: (2017) -
SARS-CoV-2 vaccine development
por: Mtewa, Andrew G., et al.
Publicado: (2022) -
Comparing and Contrasting MERS, SARS-CoV, and SARS-CoV-2: Prevention, Transmission, Management, and Vaccine Development
por: Oves, Mohammad, et al.
Publicado: (2020)